Ledger.Open graph →
SEC Form D · filed December 19, 2018

Amphivena Therapeutics, Inc

Offering
$50.0M
Sold
$38.7M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jeanmarie Guenot · SOUTH SAN FRANCISCO, CAExec · DirectorEric Moessinger · ST. LOUIS, MODirectorLuke Evnin · Boston, MADirectorPeter Van Vasselaer · SOUTH SAN FRANCISCO, CAExec · DirectorMark Mcdade · San Francisco, CADirectorChristian Richard · San Francisco, CADirectorLuke Evnin · Boston, MADirectorPeter Van Vasselaer · SOUTH SAN FRANCISCO, CAExec · DirectorMark Mcdade · Boston, MADirectorJeanmarie Guenot · Great Neck, NYExec · DirectorEric Moessinger · ST. LOUIS, MODirectorChristian Richard · SOUTH SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗